C3.ai, Inc. (AI) vs BioNTech SE (BNTX)
A side-by-side comparison of C3.ai, Inc. and BioNTech SE across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.
Different business models: AI is classified in Technology; BNTX is classified in Healthcare. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
AI
C3.ai, Inc.
$10.54TechnologyDelayed quote: Sep 11, 2026, 4:00 PM EDT
BNTX
BioNTech SE
$96.73HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT
Total return — AI vs BNTX
growth of $100 · dividends reinvested · last 6yAI -88.7% (-30.4%/yr)BNTX -20.5% (-3.7%/yr)BNTX compounded faster over this window
Log scale — wide-divergence pair
AI BNTX
AI vs BNTX: by the numbers
- •BNTX is the larger company ($24.30B vs $1.60B market cap).
- •Both run net losses; BNTX's is the smaller (-62.98% vs -192.10% net margin).
- •BNTX grew revenue faster over the past five years (40.61% vs 3.56% CAGR).
Metrics side by side
Valuation
| Metric | AI | BNTX |
|---|---|---|
| P/S ratio | 6.89 | 7.85 |
| P/B ratio | 2.30 | 1.20 |
| FCF yield | N/A | 2.55% |
Profitability
| Metric | AI | BNTX |
|---|---|---|
| Gross margin | 29.09% | 70.98% |
| Operating margin | -198.43% | -22.63% |
| Net margin | -192.10% | -62.98% |
| ROE | -64.24% | -9.62% |
| ROIC | -61.51% | -10.37% |
Growth (annualized)
| Metric | AI | BNTX |
|---|---|---|
| Revenue CAGR (5Y) | 3.56% | 40.61% |
| Total return CAGR (5Y) | -26.86% | -22.49% |
Frequently asked
- Which has grown faster, AI or BNTX?
- Over the past five years, BNTX grew revenue faster — AI at a 3.56% CAGR versus BNTX at 40.61%.
- How have AI and BNTX total returns compared?
- Over the past 5 years, AI delivered -26.86% and BNTX delivered -22.49% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
C3.ai ROEBioNTech SE ROEC3.ai operating marginBioNTech SE operating marginC3.ai revenue growthBioNTech SE revenue growthC3.ai free cash flowBioNTech SE free cash flow
C3.ai & BioNTech SE appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.